1-11 of 11
Li Xu
Close
Sort by
Journal Articles

Successful 24-Hours Manufacture of Anti-CD19/CD22 Dual Chimeric Antigen Receptor (CAR) T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Junfang Yang, Pengfei Jiang, Xian Zhang, MD, Jingjing Li, Yan Wu, Li Xu, Yunchao Su, Xiaona Hu, Xiaoyan Zhao, Qi Dong, Songbai Cai, Zhenguang Wang, Yuezhang Chen, Xun Ye, Jiaping He, Nanjing Lin, Wei Cao, Martina Sersch, MD PhD, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-136866
Published: 2020
Journal Articles

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Liyuan Qiu, Xin-An Lu, Fei Wu, Jianqiang Li, PhD, Dandan Chen, Xiangqun Li, Ziyu Li, Jingjing Li, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–6.
https://doi.org/10.1182/blood-2020-137299
Published: 2020
Journal Articles

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Xian Zhang, MD, Junfang Yang, Wenqian Li, Gailing Zhang, MD, Yunchao Su, Yanze Shi, Dan Song, Min Zhang, Jiujiang He, Li Xu, Jingjing Li, Xinan Lu, Jianqiang Li, PhD, Xiangqun Li, Zhongwei Xu, Ziyu Li, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-136897
Published: 2020
Journal Articles

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Pengfei Jiang, Xian Zhang, MD, Xiaobin Zhu, Qi Dong, Jiaping He, Nanjing Lin, Zhenguang Wang, Songbai Cai, Xun Ye, Yunchao Su, Wenqian Li, Jingjing Li, Ziyao Yu, Jiujiang He, Li Xu, Dan Song, Wei Cao, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 284.
https://doi.org/10.1182/blood-2019-126429
Published: 2019
Journal Articles

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, MD PhD, Guangxun Gao, MD, Yujun Dong, MD, Chunrui Li, MD PhD, Wenrong Huang, Limo Zhang, MD, Qiang Zhu, MD, Ruifeng Yuan, MD, Li Xu, MD, Yanjie Xu, MD, Qian Xu, Shaji K. Kumar, MD, Yun Dai, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3094.
https://doi.org/10.1182/blood-2019-132076
Published: 2019
Journal Articles

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

Junfang Yang, MD, Jiaping He, Xian Zhang, MD, Zhenguang Wang, Yongliang Zhang, Songbai Cai, Zhe Sun, Xun Ye, Yan He, Lianjun Shen, MD PhD, Jiujiang He, Gailing Zhang, MD, Dan Song, Min Zhang, Xiaona Hu, Jingjing Li, Shulian Xia, Li Xu, Wei Cao, Peihua Lu
Journal: Blood
Blood (2019) 134 (Supplement_1): 825.
https://doi.org/10.1182/blood-2019-121751
Published: 2019
Journal Articles

Combined Low-Dose Homoharringtonine, Cytarabine and Granulocyte Colony-Stimulating Factor for Patients with Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Transformed From MDS

Lingyun Wu, Xiao Li, MD, PhD, Chunkang Chang, Jiying Shu, Li Xu, Zheng Zhang
Journal: Blood
Blood (2010) 116 (21): 4004.
https://doi.org/10.1182/blood.V116.21.4004.4004
Published: 2010
Journal Articles

Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield ofCD34+ Cells in autoPBSCT.

Li Xu, Chunkang Chang, Xiao Li, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2144.
https://doi.org/10.1182/blood.V114.22.2144.2144
Published: 2009
Journal Articles

The Incidence of Corrected Hypercalcemia and Its Relationship with Prognosis for Chinese Multiply Myeloma.

Xi Zhang, Chunkang Chang, Xiao Li, MD, PhD, Jiying Su, Lingyun Wu, MD, Liyu Zhou, Qi He, Li Xu, Luxi Song, Quan Pu
Journal: Blood
Blood (2009) 114 (22): 4903.
https://doi.org/10.1182/blood.V114.22.4903.4903
Published: 2009
Journal Articles

Autoimmune Thrombocytopenic Purpura in a Patient with Renal Clear Cell Carcinoma

Li Xu, Shaoxu Ying, Xiao Li, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4572.
https://doi.org/10.1182/blood.V112.11.4572.4572
Published: 2008
Journal Articles

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Franck Morschhauser, MD, John P. Leonard, MD, Luis Fayad, MD, Bertrand Coiffier, MD, STephen J. Schuster, MD, Martin J.S. Dyer, MD, Marie-Odile Petillon, MD, Morton Coleman, MD, Amina Bahkti, Heather Horne, Li Xu, MD, Nick Teoh, PhD, William A. Wegener, MD, David M. Goldenberg, MD
Journal: Blood
Blood (2006) 108 (11): 2719.
https://doi.org/10.1182/blood.V108.11.2719.2719
Published: 2006